Skip to main content
Top
Published in: Cost Effectiveness and Resource Allocation 1/2008

Open Access 01-12-2008 | Research

Is the value of a life or life-year saved context specific? Further evidence from a discrete choice experiment

Authors: Duncan Mortimer, Leonie Segal

Published in: Cost Effectiveness and Resource Allocation | Issue 1/2008

Login to get access

Abstract

Background

A number of recent findings imply that the value of a life saved, life-year (LY) saved or quality-adjusted life year (QALY) saved varies depending on the characteristics of the life, LY or QALY under consideration. Despite these findings, budget allocations continue to be made as if all healthy life-years are equivalent. This continued focus on simple health maximisation is partly attributable to gaps in the available evidence. The present study attempts to close some of these gaps.

Methods

Discrete choice experiment to estimate the marginal rate of substitution between cost, effectiveness and various non-health arguments. Odds of selecting profile B over profile A estimated via binary logistic regression. Marginal rates of substitution between attributes (including cost) then derived from estimated regression coefficients.

Results

Respondents were more likely to select less costly, more effective interventions with a strong evidence base where the beneficiary did not contribute to their illness. Results also suggest that respondents preferred prevention over cure. Interventions for young children were most preferred, followed by interventions for young adults, then interventions for working age adults and with interventions targeted at the elderly given lowest priority.

Conclusion

Results confirm that a trade-off exists between cost, effectiveness and non-health arguments when respondents prioritise health programs. That said, it is true that respondents were more likely to select less costly, more effective interventions – confirming that it is an adjustment to, rather than an outright rejection of, simple health maximisation that is required.
Literature
1.
go back to reference Dolan P, Shaw R, Tsuchiya A, Williams A: QALY maximisation and people's preferences: A methodological review of the literature. Health Econ 2005, 14: 197–208. 10.1002/hec.924PubMedCrossRef Dolan P, Shaw R, Tsuchiya A, Williams A: QALY maximisation and people's preferences: A methodological review of the literature. Health Econ 2005, 14: 197–208. 10.1002/hec.924PubMedCrossRef
2.
go back to reference Institute of Medicine: New vaccine development. Establishing priorities. Disease of importance in developing countries. Volume II. Washington DC: National Academy Press; 1986. Institute of Medicine: New vaccine development. Establishing priorities. Disease of importance in developing countries. Volume II. Washington DC: National Academy Press; 1986.
3.
go back to reference Johannesson M, Johansson P-O: Is the Valuation of a QALY Gained Independent of Age? Some Empirical Evidence. J Health Econ 1997, 16: 589–99. 10.1016/S0167-6296(96)00516-4PubMedCrossRef Johannesson M, Johansson P-O: Is the Valuation of a QALY Gained Independent of Age? Some Empirical Evidence. J Health Econ 1997, 16: 589–99. 10.1016/S0167-6296(96)00516-4PubMedCrossRef
4.
5.
go back to reference Nord E, Richardson J, Street A, Kuhse H, Singer P: Maximising health benefits vs egalitarianism: An Australian survey of health issues. Soc Sci Med 1995, 41: 1429–37. 10.1016/0277-9536(95)00121-MPubMedCrossRef Nord E, Richardson J, Street A, Kuhse H, Singer P: Maximising health benefits vs egalitarianism: An Australian survey of health issues. Soc Sci Med 1995, 41: 1429–37. 10.1016/0277-9536(95)00121-MPubMedCrossRef
6.
go back to reference Harris J: More and better justice. In Philosophy and medical welfare. Edited by: Bell J, Mendus S. Cambridge: Cambridge University Press; 1988. Harris J: More and better justice. In Philosophy and medical welfare. Edited by: Bell J, Mendus S. Cambridge: Cambridge University Press; 1988.
7.
go back to reference Harris J: Does justice require that we be ageist? Bioethics 1994, 8: 74–83. 10.1111/j.1467-8519.1994.tb00242.xPubMedCrossRef Harris J: Does justice require that we be ageist? Bioethics 1994, 8: 74–83. 10.1111/j.1467-8519.1994.tb00242.xPubMedCrossRef
8.
go back to reference Evans JG: Rationing health care by age: The case against. BMJ 1997, 314: 822–825.CrossRef Evans JG: Rationing health care by age: The case against. BMJ 1997, 314: 822–825.CrossRef
9.
go back to reference Murray C: Rethinking DALYs. In The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Edited by: Murray C, Lopez A. Geneva: WHO, Harvard University Press; 1996. Murray C: Rethinking DALYs. In The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Edited by: Murray C, Lopez A. Geneva: WHO, Harvard University Press; 1996.
10.
go back to reference Williams A: Intergenerational equity: an exploration of the 'fair innings' argument. Health Econ 1997, 6: 117–32. 10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-BPubMedCrossRef Williams A: Intergenerational equity: an exploration of the 'fair innings' argument. Health Econ 1997, 6: 117–32. 10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-BPubMedCrossRef
11.
go back to reference Mortimer D: On the relevance of personal characteristics in setting health priorities: A comment on Olsen, Richardson, Dolan & Menzel (2003). Soc Sci Med 2005, 60: 1661–1664. 10.1016/j.socscimed.2004.08.017PubMedCrossRef Mortimer D: On the relevance of personal characteristics in setting health priorities: A comment on Olsen, Richardson, Dolan & Menzel (2003). Soc Sci Med 2005, 60: 1661–1664. 10.1016/j.socscimed.2004.08.017PubMedCrossRef
13.
go back to reference Viscusi K, Aldy JE: The value of a statistical life: A critical review of market estimates throughout the world. J Risk Uncertain 2003, 27: 5–76. 10.1023/A:1025598106257CrossRef Viscusi K, Aldy JE: The value of a statistical life: A critical review of market estimates throughout the world. J Risk Uncertain 2003, 27: 5–76. 10.1023/A:1025598106257CrossRef
14.
go back to reference Smith RD, Olsen JA, Harris A: A review of methodological issues in the conduct of willingness-to-pay studies in health care: Recommendations from a review of the literature. Melbourne: Centre for Health Programme Evaluation, Monash University; 1999. Smith RD, Olsen JA, Harris A: A review of methodological issues in the conduct of willingness-to-pay studies in health care: Recommendations from a review of the literature. Melbourne: Centre for Health Programme Evaluation, Monash University; 1999.
15.
go back to reference Johnson FR, Banzhaf MR, Desvousges WH: Willingness to pay for improved respiratory and cardiovascular health: A multiple-format, stated-preference approach. Health Econ 2000, 9: 295–317. 10.1002/1099-1050(200006)9:4<295::AID-HEC520>3.0.CO;2-DPubMedCrossRef Johnson FR, Banzhaf MR, Desvousges WH: Willingness to pay for improved respiratory and cardiovascular health: A multiple-format, stated-preference approach. Health Econ 2000, 9: 295–317. 10.1002/1099-1050(200006)9:4<295::AID-HEC520>3.0.CO;2-DPubMedCrossRef
16.
go back to reference Johnson FR, Fries EE, Banzhaf HS: Valuing morbidity: an integration of the willingness-to-pay and health-status index literatures. J Health Econ 1997, 16: 641–665. 10.1016/S0167-6296(97)00012-XPubMedCrossRef Johnson FR, Fries EE, Banzhaf HS: Valuing morbidity: an integration of the willingness-to-pay and health-status index literatures. J Health Econ 1997, 16: 641–665. 10.1016/S0167-6296(97)00012-XPubMedCrossRef
17.
go back to reference Gyrd-Hanson D: Willingness to pay for a QALY. Health Econ 2003, 12: 1049–1060. 10.1002/hec.799CrossRef Gyrd-Hanson D: Willingness to pay for a QALY. Health Econ 2003, 12: 1049–1060. 10.1002/hec.799CrossRef
19.
go back to reference Nord E: The trade-off between severity and treatment effect in cost-value analysis of health care. Health Policy 1993, 24: 227–238. 10.1016/0168-8510(93)90042-NPubMedCrossRef Nord E: The trade-off between severity and treatment effect in cost-value analysis of health care. Health Policy 1993, 24: 227–238. 10.1016/0168-8510(93)90042-NPubMedCrossRef
20.
go back to reference Stolk EA, van Donselaar G, Brouwer W, Busschbach J: Reconciliation of economic concerns and health policy: Illustration of an equity adjustment procedure using proportional shortfall. Pharmacoeconomics 2004, 22: 1097–1107. 10.2165/00019053-200422170-00001PubMedCrossRef Stolk EA, van Donselaar G, Brouwer W, Busschbach J: Reconciliation of economic concerns and health policy: Illustration of an equity adjustment procedure using proportional shortfall. Pharmacoeconomics 2004, 22: 1097–1107. 10.2165/00019053-200422170-00001PubMedCrossRef
21.
go back to reference Nord E, Pinto JL, Richardson J, Menzel P, Ubel P: Incorporating societal concerns for fairness in numerical valuations of health programs. Health Econ 1999, 8: 25–39. 10.1002/(SICI)1099-1050(199902)8:1<25::AID-HEC398>3.0.CO;2-HPubMedCrossRef Nord E, Pinto JL, Richardson J, Menzel P, Ubel P: Incorporating societal concerns for fairness in numerical valuations of health programs. Health Econ 1999, 8: 25–39. 10.1002/(SICI)1099-1050(199902)8:1<25::AID-HEC398>3.0.CO;2-HPubMedCrossRef
22.
go back to reference Mortimer D: The value of thinly-spread QALYs. Pharmaceconomics 2006,24(9):845–853. 10.2165/00019053-200624090-00003CrossRef Mortimer D: The value of thinly-spread QALYs. Pharmaceconomics 2006,24(9):845–853. 10.2165/00019053-200624090-00003CrossRef
23.
go back to reference Nord E, Richardson J, Street A, Kuhse H, Singer P: Who cares about cost? Does economic analysis impose or reflect social values? Health Policy 1995, 34: 79–94. 10.1016/0168-8510(95)00751-DPubMedCrossRef Nord E, Richardson J, Street A, Kuhse H, Singer P: Who cares about cost? Does economic analysis impose or reflect social values? Health Policy 1995, 34: 79–94. 10.1016/0168-8510(95)00751-DPubMedCrossRef
24.
go back to reference Olsen JA: Production gains: Should they count in health care evaluations? Scot J Polit 1994, 41: 69–84. 10.1111/j.1467-9485.1994.tb01111.xCrossRef Olsen JA: Production gains: Should they count in health care evaluations? Scot J Polit 1994, 41: 69–84. 10.1111/j.1467-9485.1994.tb01111.xCrossRef
25.
go back to reference McKie J, Richardson J: The rule of rescue. Soc Sci Med 2003, 56: 2407–19. 10.1016/S0277-9536(02)00244-7PubMedCrossRef McKie J, Richardson J: The rule of rescue. Soc Sci Med 2003, 56: 2407–19. 10.1016/S0277-9536(02)00244-7PubMedCrossRef
26.
go back to reference Olsen JA, Richardson J, Dolan P, Menzel P: The moral relevance of personal characteristics in setting health care priorities. Soc Sci Med 2003, 57: 1163–72. 10.1016/S0277-9536(02)00492-6PubMedCrossRef Olsen JA, Richardson J, Dolan P, Menzel P: The moral relevance of personal characteristics in setting health care priorities. Soc Sci Med 2003, 57: 1163–72. 10.1016/S0277-9536(02)00492-6PubMedCrossRef
27.
go back to reference Hall J, Gerard K, Salkeld G, Richardson J: A cost-utility analysis of mammography screening in Australia. Soc Sci Med 1992, 34: 993–1004. 10.1016/0277-9536(92)90130-IPubMedCrossRef Hall J, Gerard K, Salkeld G, Richardson J: A cost-utility analysis of mammography screening in Australia. Soc Sci Med 1992, 34: 993–1004. 10.1016/0277-9536(92)90130-IPubMedCrossRef
28.
go back to reference Richardson J, Hall J, Salkeld G: The measurement of utility in multiphase health states. Int J Technol Assess Health Care 1996,12(1):149–162.CrossRef Richardson J, Hall J, Salkeld G: The measurement of utility in multiphase health states. Int J Technol Assess Health Care 1996,12(1):149–162.CrossRef
29.
go back to reference Louviere J, Hensher DA, Swait J: Stated Choice Methods, analysis and application. Cambridge, UK: Cambridge University Press; 2000.CrossRef Louviere J, Hensher DA, Swait J: Stated Choice Methods, analysis and application. Cambridge, UK: Cambridge University Press; 2000.CrossRef
30.
go back to reference Froberg D, Kane R: Methodology for measuring health-state preferences – I: Measurement Strategies. J Clin Epidemiol 1989, 42: 345–54. 10.1016/0895-4356(89)90039-5PubMedCrossRef Froberg D, Kane R: Methodology for measuring health-state preferences – I: Measurement Strategies. J Clin Epidemiol 1989, 42: 345–54. 10.1016/0895-4356(89)90039-5PubMedCrossRef
31.
go back to reference Miller GA: The magical number seven plus or minus two: Some limits on our capacity to process information. Psychol Rev 1956,63(2):81–97. 10.1037/h0043158PubMedCrossRef Miller GA: The magical number seven plus or minus two: Some limits on our capacity to process information. Psychol Rev 1956,63(2):81–97. 10.1037/h0043158PubMedCrossRef
32.
go back to reference Ryan M, Gerard K: Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy 2003, 2: 55–64.PubMed Ryan M, Gerard K: Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy 2003, 2: 55–64.PubMed
33.
go back to reference Mortimer D, Segal L: Life is cheap in the health sector: A comparison of stated-preference estimates of the value of life for health and non-health interventions. , in press. Mortimer D, Segal L: Life is cheap in the health sector: A comparison of stated-preference estimates of the value of life for health and non-health interventions. , in press.
34.
go back to reference Lenert LA, Sturley AP, Rapaport MH, Chavez S, Mohr P, Rupnow M: Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores. Schizophrenia Research 2004, 71: 155–165. 10.1016/j.schres.2003.10.010PubMedCrossRef Lenert LA, Sturley AP, Rapaport MH, Chavez S, Mohr P, Rupnow M: Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores. Schizophrenia Research 2004, 71: 155–165. 10.1016/j.schres.2003.10.010PubMedCrossRef
35.
go back to reference Lenert LA, Treadwell JR: Effects on preferences of violations of procedural invariance. Med Decis Making 1999,19(4):473–481. 10.1177/0272989X9901900415PubMedCrossRef Lenert LA, Treadwell JR: Effects on preferences of violations of procedural invariance. Med Decis Making 1999,19(4):473–481. 10.1177/0272989X9901900415PubMedCrossRef
36.
go back to reference Greene WH: Econometric Analysis. New Jersey: Prentice Hall; 1993. Greene WH: Econometric Analysis. New Jersey: Prentice Hall; 1993.
37.
go back to reference Goldstein H, Browne W, Rasbash J: Partitioning variation in multilevel models. Understanding Statistics 2002, 1: 223–31. 10.1207/S15328031US0104_02CrossRef Goldstein H, Browne W, Rasbash J: Partitioning variation in multilevel models. Understanding Statistics 2002, 1: 223–31. 10.1207/S15328031US0104_02CrossRef
38.
go back to reference ABS: Australian Bureau of Statistics (ABS) Population by Age and Sex Australian States and Territories (Catalogue No. 3201.0). Canberra: Commonwealth of Australia; 2005. ABS: Australian Bureau of Statistics (ABS) Population by Age and Sex Australian States and Territories (Catalogue No. 3201.0). Canberra: Commonwealth of Australia; 2005.
39.
go back to reference ABS: Australian Bureau of Statistics (ABS) Life Tables, Victoria 2002–2004 (Catalogue No. 3302.2.55.001). Canberra: Commonwealth of Australia; 2005. ABS: Australian Bureau of Statistics (ABS) Life Tables, Victoria 2002–2004 (Catalogue No. 3302.2.55.001). Canberra: Commonwealth of Australia; 2005.
40.
go back to reference Phillips KA: Measuring preferences for health care interventions using conjoint analysis: An application to HIV testing. Health Serv Res 2002, 37: 1681–1705. 10.1111/1475-6773.01115PubMedCentralPubMedCrossRef Phillips KA: Measuring preferences for health care interventions using conjoint analysis: An application to HIV testing. Health Serv Res 2002, 37: 1681–1705. 10.1111/1475-6773.01115PubMedCentralPubMedCrossRef
41.
go back to reference Bussbach J, Jessing J, de Charro F: The utility of health at different stages of life: a quantitative approach. Soc Sci Med 1993, 37: 153–8. 10.1016/0277-9536(93)90451-9CrossRef Bussbach J, Jessing J, de Charro F: The utility of health at different stages of life: a quantitative approach. Soc Sci Med 1993, 37: 153–8. 10.1016/0277-9536(93)90451-9CrossRef
42.
go back to reference Olsen JA, Richardson J, Dolan P, Menzel P: The moral relevance of personal characteristics in setting health care priorities. Soc Sci Med 2003, 57: 1163–72. 10.1016/S0277-9536(02)00492-6PubMedCrossRef Olsen JA, Richardson J, Dolan P, Menzel P: The moral relevance of personal characteristics in setting health care priorities. Soc Sci Med 2003, 57: 1163–72. 10.1016/S0277-9536(02)00492-6PubMedCrossRef
43.
go back to reference Hurd MD, McGarry K: Evaluation of the subjective probabilities of survival in the health and retirement study. J Human Res 1995, 30: s268–92. 10.2307/146285CrossRef Hurd MD, McGarry K: Evaluation of the subjective probabilities of survival in the health and retirement study. J Human Res 1995, 30: s268–92. 10.2307/146285CrossRef
44.
go back to reference O'Brien BJ, Spath M, Blackhouse G, Severens JL, Dorian P, Brazier J: A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. Health Econ 2003, 12: 975–981. 10.1002/hec.789PubMedCrossRef O'Brien BJ, Spath M, Blackhouse G, Severens JL, Dorian P, Brazier J: A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. Health Econ 2003, 12: 975–981. 10.1002/hec.789PubMedCrossRef
45.
go back to reference Mirowsky J: Subjective life expectancy in the US: Correspondence to actuarial life estimates by age, sex and race. Soc Sci Med 1999, 49: 967–79. 10.1016/S0277-9536(99)00193-8PubMedCrossRef Mirowsky J: Subjective life expectancy in the US: Correspondence to actuarial life estimates by age, sex and race. Soc Sci Med 1999, 49: 967–79. 10.1016/S0277-9536(99)00193-8PubMedCrossRef
47.
go back to reference Baltussen R: Priority setting of public spending in developing countries: Do not try to do everything for everybody. Health Policy 2006, 78: 149–56. 10.1016/j.healthpol.2005.10.006PubMedCrossRef Baltussen R: Priority setting of public spending in developing countries: Do not try to do everything for everybody. Health Policy 2006, 78: 149–56. 10.1016/j.healthpol.2005.10.006PubMedCrossRef
48.
go back to reference Baltussen R, Stolk E, Chisholm D, Aikins M: Towards a multi-criteria approach for priority setting: An application to Ghana. Health Econ 2006, 15: 689–96. 10.1002/hec.1092PubMedCrossRef Baltussen R, Stolk E, Chisholm D, Aikins M: Towards a multi-criteria approach for priority setting: An application to Ghana. Health Econ 2006, 15: 689–96. 10.1002/hec.1092PubMedCrossRef
49.
go back to reference Baltussen R, Asbroek A, Koolman X, Shrestha N, Bhattarai P, Niessen L: Priority setting using multiple criteria: Should a lung health programme be implemented in Nepal? Health Policy Plann 2007,22(3):178–85. 10.1093/heapol/czm010CrossRef Baltussen R, Asbroek A, Koolman X, Shrestha N, Bhattarai P, Niessen L: Priority setting using multiple criteria: Should a lung health programme be implemented in Nepal? Health Policy Plann 2007,22(3):178–85. 10.1093/heapol/czm010CrossRef
50.
go back to reference Cookson R: Willingness to pay methods in health care: A sceptical view. Health Econ 2003, 12: 891–894. 10.1002/hec.847PubMedCrossRef Cookson R: Willingness to pay methods in health care: A sceptical view. Health Econ 2003, 12: 891–894. 10.1002/hec.847PubMedCrossRef
51.
go back to reference Donaldson C, Shackley P: Willingness to pay for Health Care. In Advances in Health Economics. Edited by: Scott A, Maynard A, Elliott R. London: John Wiley; 2003. Donaldson C, Shackley P: Willingness to pay for Health Care. In Advances in Health Economics. Edited by: Scott A, Maynard A, Elliott R. London: John Wiley; 2003.
52.
go back to reference Sach T, Smith RD, Whynes DK: A league table of contingent valuation results for pharmaceutical interventions: A hard pill to swallow? Pharmacoeconomics 2007, 25: 107–27. 10.2165/00019053-200725020-00004PubMedCrossRef Sach T, Smith RD, Whynes DK: A league table of contingent valuation results for pharmaceutical interventions: A hard pill to swallow? Pharmacoeconomics 2007, 25: 107–27. 10.2165/00019053-200725020-00004PubMedCrossRef
53.
go back to reference ABS: Australian Bureau of Statistics (ABS) Census of Population and Housing 2001, Basic Community Profile (Catalogue No. 2001.0). Canberra: Commonwealth of Australia; 2002. ABS: Australian Bureau of Statistics (ABS) Census of Population and Housing 2001, Basic Community Profile (Catalogue No. 2001.0). Canberra: Commonwealth of Australia; 2002.
54.
go back to reference ABS: Australian Bureau of Statistics (ABS) National Health Survey 2004–05: Summary of Results (Catalogue No. 4364.0). Canberra: Commonwealth of Australia; 2006. ABS: Australian Bureau of Statistics (ABS) National Health Survey 2004–05: Summary of Results (Catalogue No. 4364.0). Canberra: Commonwealth of Australia; 2006.
55.
go back to reference ABS: Australian Bureau of Statistics (ABS) Census of Population and Housing 2001, Socio-Economic Indexes for Areas (Catalogue No. 2039.0). Canberra: Commonwealth of Australia; 2003. ABS: Australian Bureau of Statistics (ABS) Census of Population and Housing 2001, Socio-Economic Indexes for Areas (Catalogue No. 2039.0). Canberra: Commonwealth of Australia; 2003.
Metadata
Title
Is the value of a life or life-year saved context specific? Further evidence from a discrete choice experiment
Authors
Duncan Mortimer
Leonie Segal
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Cost Effectiveness and Resource Allocation / Issue 1/2008
Electronic ISSN: 1478-7547
DOI
https://doi.org/10.1186/1478-7547-6-8

Other articles of this Issue 1/2008

Cost Effectiveness and Resource Allocation 1/2008 Go to the issue